Assessment of Drug –Drug Interactions between Taspoglutide, a Glucagon-Like Peptide-1 Agonist, and Drugs Commonly Used in Type 2 Diabetes Mellitus: Results of Five Phase I Trials
ConclusionOverall, multiple doses of taspoglutide did not result in changes in the pharmacokinetics of digoxin, an oral contraceptive containing ethinylestradiol and levonorgestrel, lisinopril, warfarin, and simvastatin that would be considered of clinical relevance. Therefore, no dose adjustments are warranted upon co-administration.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Coumadin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Gastroenterology | Lisinopril | Simvastatin | Statin Therapy | Statistics | Study | Warfarin | Zocor